Leishmania–macrophage interactions: Insights into the redox biology

T Van Assche, M Deschacht, RAI da Luz, L Maes… - Free Radical Biology …, 2011 - Elsevier
Leishmaniasis is a neglected tropical disease that affects about 350 million individuals
worldwide. The protozoan parasite has a relatively simple life cycle with two principal …

Leishmaniasis treatment: update of possibilities for drug repurposing

VV Andrade Neto, EF Cunha Junior, VS Faioes… - 2018 - arca.fiocruz.br
The leishmaniases represent a public health problem in under-developed countries and are
considered a neglected disease by the World Health Organization (WHO). They are cuased …

Role of trypanosomatid's arginase in polyamine biosynthesis and pathogenesis

R Balaña-Fouce, E Calvo-Álvarez… - Molecular and …, 2012 - Elsevier
l-Arginine is one of the precursor amino acids of polyamine biosynthesis in most living
organisms including Leishmania parasites. l-Arginine is enzymatically hydrolyzed by …

Synthesis and Antitrypanosomal and Mechanistic Studies of a Series of 2-Arylquinazolin-4-hydrazines: A Hydrazine Moiety as a Selective, Safe, and Specific …

AH Romero, E Aguilera, L Gotopo, J Charris… - ACS …, 2022 - ACS Publications
Nitric oxide (NO) represents a valuable target to design antitrypanosomal agents by its high
toxicity against trypanosomatids and minimal side effects on host macrophages. The …

Nitric oxide and Brazilian propolis combined accelerates tissue repair by modulating cell migration, cytokine production and collagen deposition in experimental …

MM Miranda, C Panis, AHD Cataneo, SS da Silva… - PLoS …, 2015 - journals.plos.org
The fact that drugs currently used in the treatment of Leishmania are highly toxic and
associated with acquired resistance has promoted the search for new therapies for treating …

Optimization of the 2-arylquinazoline-4 (3 H) one scaffold for a selective and potent antitrypanosomal agent: modulation of the mechanism of action through chemical …

AH Romero, E Aguilera, L Gotopo, G Cabrera… - RSC Medicinal …, 2023 - pubs.rsc.org
We sought to identify a potent and selective antitrypanosomal agent through modulation of
the mechanism of action of a 2-arylquinazoline scaffold as an antitrypanosomal agent via …

Inhalable Microparticles Containing Nitric Oxide Donors: Saying NO to Intracellular Mycobacterium tuberculosis

RK Verma, AK Singh, M Mohan… - Molecular …, 2012 - ACS Publications
Although nitric oxide (NO) is a bactericidal component of the macrophage's innate response
to intracellular infections such as tuberculosis (TB), prolonged inhalation of NO gas has little …

Antileishmanial activity and inducible nitric oxide synthase activation by RuNO complex

T Marcusso Orsini, NY Kawakami… - Mediators of …, 2016 - Wiley Online Library
Parasites of the genus Leishmania are capable of inhibiting effector functions of
macrophages. These parasites have developed the adaptive ability to escape host …

S-nitrosoglutathione (GSNO) is cytotoxic to intracellular amastigotes and promotes healing of topically treated Leishmania major or Leishmania braziliensis skin …

ISF Costa, GFP de Souza… - Journal of …, 2013 - academic.oup.com
Objectives This study was designed to verify the cytotoxic activity of S-nitrosoglutathione
(GSNO) against intracellular Leishmania amastigotes and to test its efficacy as a topical …

[HTML][HTML] Porins facilitate nitric oxide-mediated killing of mycobacteria

DL Fabrino, CKE Bleck, E Anes, A Hasilik… - Microbes and …, 2009 - Elsevier
Non-pathogenic mycobacteria such us Mycobacterium smegmatis reside in macrophages
within phagosomes that fuse with late endocytic/lysosomal compartments. This sequential …